Chemical Compound

acarbose

CAS Registry Number 56180-94-0
acarbose chemical structure
Primary Record

acarbose

In stock
1,291 g
Purity
99.3 %
CAS
56180-94-0

Compound Identifiers & Properties

CAS
56180-94-0
PubChem CID
444254
SMILES
C[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)O)O[C@@H]3[C@H](O[C@H]([C@@H]([C@H]3O)O)O)CO)CO)O)O)N[C@H]4C=C([C@H]([C@@H]([C@H]4O)O)O)CO
Canonical SMILES
C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)O[C@@H]3CO)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O

Names & Synonyms

  • acarbose
  • Precose
  • Glucobay
  • Prandase
  • Acarbosa
  • Acarbosum
  • Glucor
  • Alpha-Acarbose
  • Arcabose
  • Ascarbose
  • Beta-Acarbose
  • Glucobay;
  • Precose;
  • Amylostatin J;
  • (S)-amisulpride
  • 1agm
  • 1ukt
  • Glucobay (TN)
  • Prandase (TN)
  • BAY-g 5421
  • Precose (TN)
  • Acarbosum [INN-Latin]
  • Acarbosa [INN-Spanish]
  • Bay-g-5421
  • Acarbose, >=95%
  • RefChem:934711
  • Bay g 5421
  • GlyTouCan:G08743RW
  • D0AD5C
  • D0QU8H
  • AC1L9G0J
  • CHEMBL1566
  • UNII-T58MSI464G
  • SCHEMBL16848
  • Acarbose (JAN/USAN/INN)
  • Acarbose [USAN:BAN:INN:JAN]
  • XUFXOAAUWZOOIT-SXARVLRPSA-N
  • BAYG5421
  • GTPL6791
  • DTXCID6026034
  • DTXSID8046034
  • CHEBI:94035
  • HSDB 7984
  • 56180-94-0
  • Acarbose [USAN:INN:BAN:JAN]
  • BCPP000442
  • C25H43NO18
  • HMS3269L19
  • HMS3413P19
  • HMS3677P19
  • HMS3713B18
  • G08743RW
  • EINECS 260-030-7
  • Tox21_111597
  • BDBM50333465
  • CID444254
  • EBC-46065
  • s1271
  • ZINC85537042
  • Acarbose [USAN:USP:INN:BAN:JAN]
  • AKOS024457233
  • C25-H43-N-O18
  • Tox21_111597_1
  • BCP9000224
  • CCG-220568
  • Prandase;Precose;Glucobay;Bay-g 5421
  • NCGC00159353-02
  • NCGC00160515-02
  • AB2000022
  • CAS-56180-94-0
  • ACI-(1-4)GLD-(1-4)GLC-(1-4)GLB
  • FT-0621713
  • FT-0776097
  • HMC-(1-4)AGL-(1-4)GLC-(1-4)GLC
  • NS00001516
  • droxymethyl)tetrahydro-2H-pyran-2,3,4-triol
  • J1.629.106D
  • AB01274765-01
  • AB01274765_02
  • EN300-27025603
  • Q338005
  • Prandase, Precose, Glucobay, Bay-g 5421, Acarbose
  • BRD-K44276885-001-01-7
  • BRD-K44276885-001-05-8
  • BRD-K44276885-001-07-4
  • Acarbose, European Pharmacopoeia (EP) Reference Standard
  • xy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-6-(hy
  • (2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol
  • Acarbose, United States Pharmacopeia (USP) Reference Standard
  • (2R,3R,4R,5R,6R)-5-((2R,3R,4R,5S,6R)-5-((2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-enylamino)-tetrahydro-2H-pyran-2-yloxy)-3,4-dihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yloxy)-6-(hydroxymethyl)-tetrahydro-2H-pyran-2,3,4-triol
  • (2R,3R,4R,5S,6R)-5-{[(2R,3R,4R,5S,6R)-5-{[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-(hydroxymethyl)oxane-2,3,4-triol
  • Acarbose for identification, European Pharmacopoeia (EP) Reference Standard
  • Acarbose, Pharmaceutical Secondary Standard; Certified Reference Material
  • 1,4-DEOXY-4-((5-HYDROXYMETHYL-2,3,4-TRIHYDROXYCYCLOHEX-5,6-ENYL)AMINO)FRUCTOSE
  • Acarbose for peak identification, European Pharmacopoeia (EP) Reference Standard
  • (2R,3R,4R,5S,6R)-5-(((2R,3R,4R,5S,6R)-5-(((2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl)amino)tetrahydro-2H-pyran-2-yl)oxy)-3,4-dihydro
  • (2R,3R,4R,5S,6R)-5-((2R,3R,4R,5S,6R)-5-((2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-enylamino)-tetrahydro-2H-pyran-2-yloxy)-3,4-dihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yloxy)-6-(hydroxymethyl)-tetrahydro-2H-pyran-2,3,4-triol
  • (2R,3R,4R,5S,6R)-5-((2R,3R,4R,5S,6R)-5-((2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-((1S,4S,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-enylamino)-tetrahydro-2H-pyran-2-yloxy)-3,4-dihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yloxy)-6-(hydroxymethyl)-tetrahydro-2H-pyran-2,3,4-triol
  • (2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol
  • (3R,4R,5S,6R)-5-((2R,3R,4R,5S,6R)-5-((2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-enylamino)-tetrahydro-2H-pyran-2-yloxy)-3,4-dihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yloxy)-6-(hydroxymethyl)-tetrahydro-2H-pyran-2,3,4-triol
  • 4,6-Dideoxy-4-([1S]-[1,4,6/5]-4,5,6-trihydroxy-3-hydroxymethyl-2-yclohexenylamino)maltotriose
  • 4-O-[4-O-[4-[[(1S,4R,5S,6S)-4,5,6-Trihydroxy-3-hydroxymethyl-2-cyclohexene-1-yl]amino]-4,6-dideoxy-alpha-D-glucopyranosyl]-alpha-D-glucopyranosyl]-beta-D-glucopyranose
  • 4?,6?-dideoxy-4?-[(1S)-(1,4,6/5)-4,5,6-trihydroxy-3-hydroxymethyl-2-cyclohexenylamino]maltotriose
  • 5-{5-[3,4-Dihydroxy-6-methyl-5-(4,5,6-trihydroxy-3-hydroxymethyl-cyclohex-2-enylamino)-tetrahydro-pyran-2-yloxy]-3,4-dihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy}-6-hydroxymethyl-tetrahydro-pyran-2,3,4-triol
  • 71675-92-8
  • ACR
  • D-glucosa, o-4,6-dideoxi-4-[[(1s,4r,5s,6s)-4,5,6-trihidroxi-3-(hidroximetil)-2-ciclohexen-1-il]amino]-?-d-glucopiranosil-(1?4)-o-?-d-glucopiranosil-(1?4)-
  • D-Glucose, O-4,6-dideoxy-4-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-.alpha.-D-glucopyranosyl-(1->4)-O-.alpha.-D-glucopyranosyl-(1->4)-
  • O-4,6-Dideoxy-4-(((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-alpha-D-glucopyranosyl-(1->4)-O-alpha-D-glucopyranosyl-(1->4)-D-glucose
  • O-4,6-Dideoxy-4-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-?-D-glucopyranosyl-(1-4)-O-?-D-glucopyranosyl-(1-4)-D-Glucose